Heavy metals and female hormones: what cadmium and lead can do
Cadmium binds to the estrogen receptor. Lead sits in bone for decades. What of this is documented in humans, what comes from cell culture and animal models, and which everyday lever counts most.
You are sitting in the consulting room, and I ask you whether you smoke. Then whether you used to smoke. Then about your ferritin, and after that how heavy your period is. Meanwhile you are here because of cycle complaints, because of fibroids or endometriosis. And you think to yourself: what does one have to do with the other?
It has more to do with each other than most guides tell you. And less than some elimination blogs claim. This text sits in between.
Cadmium and lead are not exotic poisons from a chemical accident. They are everyday: cigarette smoke, grains, vegetables, organ meats, shellfish, cocoa. And some of them can dock where estrogen otherwise docks. That is a well measured mechanism. What follows from it for your menstrual cycle is an entirely different question.
With hormonal complaints I ask about environmental factors because the mechanisms are documented. That does not mean I claim your complaints come from metals. Holding both at once is the whole trick.
This article is for the woman who wants to know after the appointment why I ask these questions. And for the woman who read online that cadmium raises the endometriosis risk 3.4-fold and has felt bad ever since. That number does not appear here, because I could not find its source. What I did find is here in full, including where it contradicts environmental medicine.
Environmental medicine is an addition. It comes after the medical work-up, not in its place. The following situations belong in medical hands promptly, regardless of any metal value:
- any bleeding after menopause
- very heavy or suddenly changed bleeding
- lower abdominal pain with fever
- acute, one-sided lower abdominal pain
- unintended weight loss
- visual disturbances or headaches together with milky discharge from the breast
- rapidly progressing virilisation, meaning sudden strong hair growth, a deeper voice, hair loss on the head
And a second sentence that matters just as much: if you take the pill, are on hormone replacement therapy, take thyroid hormones, metformin, antiandrogens or GnRH analogues, do not change any of it because of this article. Every adjustment belongs under medical supervision.
These four colours will accompany you through the text. In this field, almost everything depends on whether a sentence comes from a petri dish, from a rat or from a woman. That is the most common mistake online, in both directions.
What lies ahead
- Where the term metalloestrogen comes from and where it ends
- Cadmium at the estrogen receptor: the cell and animal data
- What has been measured in humans: menstrual cycle, hormones, ovarian reserve
- Endometriosis and fibroids: two studies, two directions
- Menopause: why the popular claim does not hold
- Lead, fertility and the bone store
- Mercury, thyroid, arsenic: the indirect routes
- Everyday sources and what blood, urine and hair show
- What may actually lower intake
Metalloestrogen: what the term means and where it ends
Imagine a lock. The lock on a door behind which the building instructions for the uterine lining, the mammary gland and part of your mood are kept. The key is called estradiol, and your body makes it itself, in the rhythm of your cycle.
And now the uncomfortable part. This lock is not particularly choosy. Other molecules fit into it as well. Some from plants, some from plastics, some from moulds. And some are simply metal ions.
The word metalloestrogen comes from a review by Darbre from 2006, published in the Journal of Applied Toxicology. It brings together metal ions that bind to estrogen receptors and can trigger an estrogen-like response there in the laboratory. The list is longer than you would expect: aluminium, antimony, arsenite, barium, cadmium, chromium, cobalt, copper, lead, mercury, nickel, selenite, tin and vanadate.
Who: Darbre, School of Biological Sciences, University of Reading, United Kingdom, 2006.
What: A synthesis of the metal ions known at the time to bind to estrogen receptors. The core statement is that environmental estrogens need not only be organic molecules, they can also be inorganic.
What this means for you: The term describes a receptor binding in the laboratory. It is a description of chemistry, not a diagnosis and not a statement about your body.
Darbre PD. J Appl Toxicol. 2006;26(3):191-197. DOI: 10.1002/jat.1135 · PMID: 16489580 [Mechanism Review]Here is the first distinction, and it matters. A metalloestrogen is something different from a xenoestrogen made of plastic. Xenoestrogens are organic molecules, often from packaging, cosmetics or pesticides, and they carry their own cluster of questions. We already have a separate text on that, so I will not go into it here and instead point you to xenoestrogens in everyday life. And there is a third family, the mycoestrogens from moulds, above all zearalenone. We have a separate article on that too: zearalenone and hormones.
Zearalenone is a documented mycoestrogen. Cadmium is a well studied metalloestrogen. It does not follow from this that every hormonal disorder has an environmental cause. It only follows that it is worth asking about when the usual explanations do not fit.
So why does this article exist at all? Because the word has had a strange career online. On agency websites it does not appear, there the subject is kidney values. On elimination blogs it is a magic word with a therapy standing right behind it. The two sides talk past each other, and in between sits a woman with cycle complaints.
A receptor that can be occupied is not proof that it is occupied in everyday life. And even if it is occupied, it has not yet been shown that complaints arise from it.
But the reverse holds just as much: the fact that the chain of evidence has gaps does not make the mechanism wrong. It only makes it a question instead of an answer. Asking is allowed. Answering should be backed up.
And now you know why I pause briefly at the word metalloestrogen in the consulting room instead of acting straight away. It is a good starting point for a conversation and a poor starting point for a treatment.
Cadmium at the estrogen receptor: cell culture, animal model and the line between them
When you read online that cadmium mimics estrogen, that sentence almost always traces back to two papers. Both are well done, neither was carried out in humans, and both are almost never cited with that label attached.
The first is from 2000, from the Lombardi Cancer Center at Georgetown University in Washington. A team around Stoica measured how tightly cadmium sits on estrogen receptor alpha.
Who: Stoica, Katzenellenbogen and Martin, 2000, Molecular Endocrinology. Transfection experiments in COS-1 cells, plus Scatchard analyses with human receptor protein and extracts from MCF-7 breast cells.
What was observed: Cadmium activated the receptor from concentrations of 10 to the minus 11 moles per litre upwards. The equilibrium dissociation constant was roughly 4 to 5 times 10 to the minus 10 moles per litre. Cadmium did not block estradiol binding competitively. The antiestrogen ICI-164,384 abolished the effect, which shows that it does indeed run through the receptor.
What this means for you: The binding is real and well characterised. It took place in cells in a dish, not in a body with a liver, kidneys and its own hormone household.
Stoica A, Katzenellenbogen BS, Martin MB. Mol Endocrinol. 2000;14(4):545-553. DOI: 10.1210/mend.14.4.0441 · PMID: 10770491 [In vitro]The second paper is the more famous one. In 2003, Nature Medicine published an experiment showing that this does not only play out in a dish. Ovariectomised rats, meaning rats without ovaries and therefore without their own estrogen source, were given cadmium.
Who: Johnson and colleagues, 2003, Nature Medicine, Georgetown University. Model: Sprague-Dawley rats.
What was observed: After cadmium exposure the wet weight of the uterus rose, the lining proliferated, progesterone receptor and complement component C3 were upregulated. In the mammary gland there were more side branches and more alveolar buds. After exposure already in the womb, puberty began earlier in the female offspring, with a larger epithelial area and more terminal end buds.
What this means for you: A strong finding, produced in rats, with a defined dose and a defined route of administration. Whether a woman with everyday exposure experiences the same has not been shown to this day.
Johnson MD, Kenney N, Stoica A et al. Nat Med. 2003;9(8):1081-1084. DOI: 10.1038/nm902 · PMID: 12858169 [In vivo, rat]In 2020 the same effect was added for arsenite, in a paper in Carcinogenesis. There too the increase could be blocked with an antiestrogen, and after additional exposure to a carcinogen, tumours appeared more often and earlier. What is interesting is what was not different: total number, multiplicity and volume of the tumours did not differ. Such distinctions show how limited an effect can be, even when it is statistically there.
And then there is one more finding that is particularly interesting for this topic. At the US environmental institute NIEHS, work was done in 2021 on human fibroid cells, meaning cells from a uterine leiomyoma line.
Who: Yu and colleagues, 2021, Archives of Toxicology, NIEHS, Research Triangle Park, North Carolina. Immortalised human leiomyoma cells.
What was observed: Cadmium raised division markers such as PCNA and phosphorylated histone H3, along with pMAPK44/42, FOXM1, phosphorylated Aurora B and cyclin D1. An inhibitor of MEK kinase dampened these effects again. The route ran through the G protein coupled estrogen receptor, not through the classical nuclear receptor.
What this means for you: There is a plausible path along which cadmium might stimulate fibroid cells to divide. Between this cell culture and your ultrasound finding lie many steps that nobody has demonstrated.
Yu L, Liu J, Yan Y et al. Arch Toxicol. 2021;95(6):1995-2006. DOI: 10.1007/s00204-021-03033-z · PMID: 33818655 [In vitro]What the path from metal to hormone signal looks like
- Cadmium enters the circulation through the lungs or the gut. Through the lungs very efficiently, through the gut only at a few percent, depending on iron status.
- In the blood it binds to metallothionein, a small sulphur-rich transport protein, and is carried to the kidney.
- Part of it reaches cells with estrogen receptors. There cadmium can dock onto the hormone binding domain, at the same sites where estradiol otherwise sits.
- The receptor can then switch on the same genes as with a real hormone signal. In the animal model this could be read off the uterus and the mammary gland.
- Whether this step plays a role in the human body at everyday exposure is open. Human cells do not stand in a dish, they stand in a system with counter-regulation.
Steps 1 to 3 are well documented. Step 4 comes from the animal. Step 5 is the honest part, and it is the reason this article contains no treatment recommendation.
Three reasons why cell and animal data do not carry through here
First, the dose. In cell culture a concentration is set. In the body what matters is how much arrives, how much is bound, how much the kidney holds back.
Second, the route. An animal receives a defined dose. You take up cadmium over decades in tiny portions. Those are two different processes.
Third, the species. The rat has a different cycle and a different kidney physiology. An earlier onset of puberty in rat pups is a finding about rats.
This is not a dismissal of these papers. They are the reason anyone looked in humans at all.
An animal experiment is not a weaker truth. It is an answer to a different question. It answers whether something is biologically possible. It does not answer whether it happens in you.
And now you know why, with the sentence cadmium mimics estrogen, I always ask in which species. It is correct. It is just not about humans.
What has been measured in humans: menstrual cycle, hormone levels, ovarian reserve
Many women know this pattern. The period comes irregularly, the second half of the cycle feels sluggish, and the values that were taken all sit somewhere within the reference range. Then the thought appears that it could be environmental exposure. A legitimate question. It even has data behind it.
The best work on cycle hormones and metals is called BioCycle and comes from Buffalo, New York. It is so good because it did not take blood once, but up to eight times per cycle.
Who: A team around Pollack, 2011, Environmental Health Perspectives. 252 women between 18 and 44 years of age, followed over up to two cycles, metals in whole blood by mass spectrometry.
What was observed: The geometric means were 0.29 micrograms per litre for cadmium, 0.93 micrograms per decilitre for lead and 1.03 micrograms per litre for mercury. FSH fell with rising cadmium, by 10.0 percent in the second versus the first tertile, with a confidence interval of minus 17.3 to minus 2.5. Progesterone rose with lead, by 7.5 percent in the second tertile. And the most important finding: no association with anovulation. Ovulation itself was unremarkable.
What this means for you: Shifts in cycle hormones are measurable, but small. The function that matters was not impaired.
Pollack AZ, Schisterman EF, Goldman LR et al. Environ Health Perspect. 2011;119(8):1156-1161. DOI: 10.1289/ehp.1003284 · PMID: 21543284 [Cohort, n=252]Ten percent less FSH sounds like a lot. It is not. Within a single woman's cycle, FSH swings by a multiple of that. A ten percent difference between two groups is a statistical signal, not a finding you would feel in yourself. Which hormone value is meaningful and when is covered in hormone testing in women.
The second big question is ovarian reserve, usually measured as anti-Muellerian hormone. There is a paper on this from the SWAN cohort, one of the best long-term studies on the menopausal transition anywhere.
Who: A team around Ding, 2024, Journal of Clinical Endocrinology and Metabolism, University of Michigan, Ann Arbor. 549 women, 2252 repeated AMH measurements from ten years to zero years before the final menstrual period.
What was observed: Women in the highest arsenic tertile had 32.1 percent less AMH at the time of the final period than women in the lowest tertile, with a confidence interval of minus 52.9 to minus 2.2. For mercury it was minus 40.7 percent. Cadmium and mercury were additionally accompanied by a faster annual AMH decline, for cadmium minus 9.0 percent per year.
What this means for you: The best hint so far that metals might play a part in ovarian reserve. It remains an observational study, and AMH is a group marker, not a prognosis for an individual woman.
Ding N, Wang X, Harlow SD et al. J Clin Endocrinol Metab. 2024;109(11):e2057-e2064. DOI: 10.1210/clinem/dgad756 · PMID: 38271266 [Cohort, n=549]And now the counter-finding that appears in no elimination blog. In western France, four fertility centres examined whether women with diminished ovarian reserve have higher metal values than women without. 139 cases, 153 controls.
When the signal disappears as soon as you adjust
Unadjusted, it looked like something. Chromium came to an odds ratio of 2.07 with a confidence interval of 1.04 to 4.13. The second cadmium tertile was at 1.87 with 1.06 to 3.30.
After adjustment for the confounders examined, neither was significant any more. The mixture analyses also produced nothing. The authors report this openly.
A lesson in itself. Smoking is at once the largest cadmium source and a risk factor in its own right for fertility and early menopause. Anyone who does not adjust for it is measuring smoking and calling it cadmium.
Génard-Walton M, Warembourg C, Duros S et al. Reprod Biomed Online. 2023;47(3):103241. DOI: 10.1016/j.rbmo.2023.05.013 · PMID: 37451971 [Case-Control, n=292]When two good studies point in different directions, that is not a sign of bad science. It is a sign that the effect, if it exists, is small. Large effects do not hide.
For you that means: a metal value does not answer the question of why your cycle has changed. It is one puzzle piece among many, and usually not the biggest one.
And now you know why, with cycle complaints, I do not start with a metal test but with thyroid, iron, stress and sleep. Metals come later, if they come at all.
Endometriosis and fibroids: the contradictory evidence, honestly sorted
This is the section many women find this article for. And the one in which I choose my words most carefully. Not out of reticence, but because the data demand it.
First a sentence that stands above everything. Endometriosis and fibroids are medical diagnoses. They belong in gynaecological care for assessment, and an indicated operation or laparoscopy is not replaced or postponed by any environmental thought. The environmental question comes on top. You will find the larger context under endometriosis seen integratively.
Endometriosis: two studies, two directions
In 2023, Human Reproduction published an analysis from four NHANES cycles, meaning from the large US health survey. It is the source for almost all German articles on the topic.
Who: A team around Hall, 2023, Michigan State University, East Lansing. Women between 20 and 54 years of age with cadmium in urine, endometriosis by self-report in the interview.
What was observed: In the second versus the first quartile, the adjusted prevalence ratio was 2.0 with a confidence interval of 1.1 to 3.9. In the third quartile likewise 2.0 with 1.1 to 3.7. And in the fourth, the highest quartile, only 1.6 with 0.8 to 3.2, so no longer significant.
What this means for you: There is a signal, but it does not rise with exposure. With a genuine dose effect, the highest quartile would be the strongest. That is exactly what it is not.
Hall MS, Talge NM, Upson K. Hum Reprod. 2023;38(9):1835-1842. DOI: 10.1093/humrep/dead117 · PMID: 37487110 [Cross-sectional, n=1647]Now the other study. The ENDO study secured the diagnosis surgically: 473 women who were being operated on anyway, plus a population cohort with MRI diagnosis. That removes the largest source of error, self-report.
With a surgically confirmed diagnosis, cadmium points the other way
In the population cohort, not a single element was associated with endometriosis.
In the surgical cohort, cadmium in blood was linked to a lower probability, an adjusted odds ratio of 0.55 with a confidence interval of 0.31 to 0.98. Raised there instead were chromium in urine at 1.97 and copper in urine at 2.66.
I am not going to dissolve this contradiction, because the data do not dissolve it. Anyone who quotes only one of the two studies creates a picture the literature does not support. In whichever direction.
Pollack AZ, Buck Louis GM, Chen Z et al. Reprod Toxicol. 2013;42:41-48. DOI: 10.1016/j.reprotox.2013.05.009 · PMID: 23892002 [Cohort, n=473]If you have endometriosis: you did not bring this on yourself. Not through your food, not through your flat, not through anything you could have avoided. Endometriosis is a complex condition with genetic, immunological and hormonal components. Everything written here about metals is a possible side stage and not a verdict.
Fibroids: somewhat more consistent, but weak
With fibroids the picture is a little more uniform. The same surgical cohort found an adjusted odds ratio of 1.44 with 1.02 to 2.04 for whole blood cadmium, 1.31 with 1.02 to 1.69 for whole blood lead and 1.31 for urinary cobalt. The catch: cadmium and lead in urine were not associated. When blood and urine give different answers, that is a warning sign.
The study group itself considers that a fibroid could also be a reservoir for these elements. So not the metal makes the fibroid, but the fibroid binds the metal. That is reverse causality, and here it is not an excuse but a serious possibility.
The best prospective work so far is from 2025 and comes from the SELF cohort in the Detroit area. Prospective means: first the measurement, then the waiting, then the look at who newly develops a fibroid. Ultrasound at the start and after 20 months.
Who: A team around Geller, 2025, Environmental Health Perspectives. 1132 participants who were fibroid-free at the start, 17 metals in whole blood, plus vitamin D in serum.
What was observed: 832 of the women, meaning 73 percent, had a vitamin D deficiency. 117 women, meaning 10 percent, developed a fibroid within 20 months. The metal mixture was weakly positively associated. For cadmium an association appeared only in the subgroup with vitamin D deficiency, with a confidence interval of 1.07 to 2.24. The authors call their own findings, in their own words, weak and imprecise.
What this means for you: When even the best prospective dataset finds only a weak signal, the effect is small. The vitamin D hint shows that this is about interplay, not about a single poison.
Geller RJ, Wesselink AK, Claus Henn B et al. Environ Health Perspect. 2025;133(3-4):47012. DOI: 10.1289/EHP15218 · PMID: 40063901 [Cohort, prospective, n=1132]For context, one more reassuring finding. In a Danish cohort of 23815 postmenopausal women, the incidence rate ratio per additional 10 micrograms of dietary cadmium per day was 0.99 for breast cancer, 1.08 for endometrial cancer and 1.15 for ovarian cancer, each with intervals that include 1. So nothing.
And now you know why, with fibroids and endometriosis, I talk first about the gynaecological treatment, about bleeding intensity, about iron and about pain. And only afterwards, if at all, about metals. If the estrogen metabolism behind it interests you, you will find it under understanding estrogen dominance.
Menopause: what the numbers say about the timing of the final period
One sentence has been travelling through German health websites for years: that cadmium brings menopause forward. I considered it plausible myself for a long time. It fits the mechanism narrative and sounds logical.
The most recent work on it shows the opposite.
Who: A team around Yin, 2025, BMC Public Health, Peking Union Medical College Hospital and Chinese Academy of Medical Sciences, Beijing. 414 women in early postmenopause, meaning 12 to 24 months after the final period.
What was observed: Per unit of log-transformed cadmium, menopause occurred on average 1.30 years later, with a confidence interval of 0.12 to 2.48. Lead was linked to a menopause on average 1.25 years earlier, with minus 2.43 to minus 0.07. The metal mixture as a whole showed no significant association. The associations were weaker at a body weight within the normal range and with at least seven hours of sleep.
What this means for you: For lead the direction fits the widespread narrative, for cadmium it does not. The study group itself stresses that this is a cross-section and the temporal order remains unclear.
Yin G, Zhao S, Wu J, Xu Q. BMC Public Health. 2025;26(1):26. DOI: 10.1186/s12889-025-25306-3 · PMID: 41316068 [Cross-sectional, n=414]Why a cross-section is such a large problem here
A cross-section measures everything at the same time. So today's metal value and yesterday's age at menopause. That is roughly like measuring adults' shoe sizes and concluding from that how fast they ran as children.
With lead there is an additional twist. Lead sits in bone, and bone is remodelled faster after menopause because estrogen is missing. If more lead is in the blood afterwards, that can mean lead accelerated menopause. It can just as well mean menopause released the lead. Both explanations produce the same number.
When two opposite explanations produce the same number, the number is not proof. It is an invitation to measure better.
Reverse causality, in one sentenceAlongside this there is something better documented that gets mentioned less often: in human observational studies smoking itself counts as a factor for earlier menopause. And smoking is at the same time the largest cadmium source.
The timing of your menopause is to a large extent laid down in your family history. Smoking can shift it forward, and that is well documented in human observational studies. Everything else you find online on this moves in a range of months to a few years, with wide confidence intervals and contradictory signs.
If your perimenopause runs early and hard, the more productive question is not which metal is to blame. The more productive question is what can be improved right now in sleep, blood sugar, iron, thyroid and load.
What actually becomes a topic in this phase of life we describe in detail elsewhere: perimenopause and when it begins as well as the question of what may ease things during menopause. And because the iron store is often a blind spot in this phase, it is also worth a look at iron deficiency in menopause.
And now you know why I no longer use that one sentence from the internet. Not because environmental medicine were unimportant. But because the most recent number points the other way, and then you say so.
Lead: fertility, pregnancy and the bone store
Lead is the quieter candidate. It does not bind to the estrogen receptor as spectacularly as cadmium and therefore appears less often in guide texts. In the human data, however, it is the metal with the most robust signals. That reversal surprised me too.
Time to pregnancy: a couple matter
The LIFE study is one of the best papers on environmental factors and fertility. 501 couples were followed from the moment they stopped contraception, with diaries and tests, for up to twelve months.
Who: A team around Buck Louis, 2012, Chemosphere, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, Maryland.
What was observed: A fecundability odds ratio below 1 means a longer time to pregnancy. For cadmium in the woman it was 0.78 with 0.63 to 0.97, for lead in the man 0.85 with 0.73 to 0.98. In the joint couple model only lead in the man remained, at 0.82 with 0.68 to 0.97. Cotinine, meaning the smoking marker, was adjusted for.
What this means for you: Fertility is a couple matter, and here that was not merely claimed but measured. Because smoking was adjusted for, the finding is more robust than most others in this article.
Buck Louis GM, Sundaram R, Schisterman EF et al. Chemosphere. 2012;87(11):1201-1207. DOI: 10.1016/j.chemosphere.2012.01.017 · PMID: 22309709 [Cohort, prospective, 501 couples]A later overview from the same research group confirmed this: for lead in the man the fecundability odds ratio was 0.83 with 0.70 to 0.98, after adjustment for the partner's values.
If you are trying to conceive, the order is decisive. Reproductive medical assessment belongs at the beginning, not at the end. Time is a real, biological factor in this area, and no environmental question justifies postponing it.
What remains sensible alongside and independently of that: quitting smoking in both partners, an orderly iron status and good nutrient supply. These are things that are useful even if metals turn out to play no role.
Pregnancy: pre-eclampsia, honestly placed
On lead and pre-eclampsia there is a meta-analysis from 2022 that pools 21 studies. It compared 1533 women with pre-eclampsia against 10998 healthy pregnant women. The standardised mean difference was 1.06 with a confidence interval of 0.69 to 1.43.
Sounds unambiguous. It is not. Heterogeneity was 96.4 percent, a value at which, strictly speaking, one should no longer pool. The association has been found repeatedly. That single number still does not carry. Pre-eclampsia has many causes and is a core topic of antenatal care, with blood pressure measurement, urine testing and ultrasound. Nothing in this article changes that.
The bone store: the underestimated point, with both sides
Lead behaves in the body somewhat like calcium. It is built into bone and stays there, with half-lives measured in decades. Part of your current lead burden comes from a time when petrol still contained lead.
And now the thought I consider underestimated. Bone is not a safe, it is an account. Where bone is remodelled, stored lead can return to the circulation. Two such phases are pregnancy and breastfeeding, a third is menopause.
Who: A team around Hernandez-Avila, 2000, Archives of Environmental Health, Instituto Nacional de Salud Publica, Cuernavaca, Mexico. Survey in Mexico City between 1993 and 1995.
What was observed: Blood lead values ranged from 1.0 to 43.8 micrograms per decilitre, on average 11.0. Women in menopause had the highest values. The mean difference between women before and after menopause was 0.76 micrograms per decilitre with a confidence interval of 0.024 to 1.48. Across age an inverted U-shaped course appeared, with a maximum between 47 and 50 years.
What this means for you: This is the origin of the bone store idea. The exposure of that population was well above what is usual in Germany today, and lead-glazed ceramics were a relevant source there. The order of magnitude cannot be transferred one to one.
Hernandez-Avila M, Villalpando CG, Palazuelos E et al. Arch Environ Health. 2000;55(5):355-360. DOI: 10.1080/00039890009604028 · PMID: 11063411 [Cross-sectional, n=903]When you measure the bone directly, it does not change
At Mount Sinai School of Medicine in New York, 91 women were followed prospectively who underwent bilateral removal of the ovaries for a benign indication. So a menopause that can be dated to the day. Not only blood was measured, but also lead in the shin bone by X-ray fluorescence.
Median blood lead rose by 0.4 micrograms per decilitre after six months, by 0.7 in women without estrogen replacement. Between six and eighteen months nothing changed further. And lead in the shin bone did not change significantly. The authors' conclusion: no evidence of substantial mobilisation from cortical bone.
Both findings stand side by side, and I am not going to dissolve them. One measures blood in a heavily exposed population, the other the bone itself in a lightly exposed one.
Berkowitz GS, Wolff MS, Lapinski RH, Todd AC. Environ Health Perspect. 2004;112(17):1673-1678. DOI: 10.1289/ehp.7005 · PMID: 15579412 [Cohort, prospective, n=91]One paper is practically the most important in this article for me, because it is randomised. Chance decides who gets what, and therefore something can be said about cause and effect instead of only about associations.
Who: A team around Hernandez-Avila, 2003, Epidemiology. 617 breastfeeding women in Mexico City, mean age 24 years, mean blood lead 8.5 micrograms per decilitre. Double-blind randomised to 1200 milligrams of elemental calcium as calcium carbonate daily or placebo, over six months.
What was observed: In the analysis of all participants, blood lead fell by 0.29 micrograms per decilitre with a confidence interval of minus 0.85 to 0.26, so not significant. In the subgroup with good adherence and a high bone lead burden, the estimated decrease was 1.16 micrograms per decilitre with minus 2.08 to minus 0.23, corresponding to 16.4 percent.
What this means for you: A nutrient can measurably influence the lead burden, moderately and limited to a subgroup. Because this concerns pregnancy and breastfeeding: every supplement there belongs under medical supervision, without exception.
Hernandez-Avila M, Gonzalez-Cossio T, Hernandez-Avila JE et al. Epidemiology. 2003;14(2):206-212. DOI: 10.1097/01.EDE.0000038520.66094.34 · PMID: 12606887 [RCT, n=617]What lead otherwise does in the body and which values are considered abnormal in Germany is covered under lead: symptoms and sources. Pregnancy and childhood follow their own rules: heavy metals in pregnancy and childhood.
In this topic, bone is not a problem but a buffer. For decades it took something out of the circulation. That some of it can come back during remodelling phases is the flip side of a protective service.
And now you know why I sometimes ask women in the menopausal transition about calcium supply, without it being only about bone density.
Mercury, thyroid and arsenic: the indirect routes
Not every route from metal to hormone runs through the estrogen receptor. Two detours are better documented than the direct route: one through the thyroid, the other through blood sugar.
Mercury and the thyroid
Your thyroid is the pacemaker hardly anyone has on their radar when the cycle goes off track. It co-regulates cycle length, bleeding intensity, ovulation and the binding protein your sex hormones hang on. When the thyroid tips, the cycle tips with it.
Who: A team around Hu, 2021, Environmental Research, Nanjing Medical University. Of 18 identified papers, 13 entered the quantitative analysis.
What was observed: Mercury in blood was associated with a higher TSH, beta 0.55 with a confidence interval of 0.20 to 0.90. Likewise with a higher free T4, beta 0.47 with 0.11 to 0.82. Total T4 behaved in the opposite direction. In subgroups the TSH effect appeared in children and adolescents, the FT4 effect in pregnant women.
What this means for you: Shifts of laboratory values in groups, not diagnoses. But they are enough to explain why, with an unclear thyroid picture, I also ask about exposure.
Hu Q, Han X, Dong G et al. Environ Res. 2021;196:110928. DOI: 10.1016/j.envres.2021.110928 · PMID: 33640496 [Meta-analysis, k=13]A finding from the Spanish INMA birth cohort with 1407 pregnant women fits with this. Mercury in cord blood was borderline inversely associated with total T3, with a beta of minus 0.05 and an interval of minus 0.10 to 0.01. The association was clearer in the women who supplemented iodine, there minus 0.08 with minus 0.15 to minus 0.02. So the effect depends on iodine status. Exactly these interactions explain why studies in this field so often point in different directions.
How thyroid and female hormones interact is covered under thyroid and female hormones. On metals and Hashimoto there is heavy metals and Hashimoto, on mercury itself understanding mercury.
Arsenic and gestational diabetes
The second detour runs through sugar metabolism, and that is more tightly interlocked with your hormones than it sounds. Insulin co-regulates androgen production in the ovaries and can influence the binding protein SHBG in the liver. That is why the blood sugar axis turns up in almost every hormone topic, described under insulin resistance and hormones in women.
On arsenic and gestational diabetes there are two independent meta-analyses. The first from 2020 from the San Raffaele Institute in Milan pooled nine papers with 1984 cases, pooled risk 1.56 with 1.23 to 1.99, heterogeneity moderate at 64 percent. The second from 2024 from Shenyang covered 13 studies with 2575 cases, odds ratio 1.47 with 1.11 to 1.95.
Two groups, two datasets, the same direction, a similar order of magnitude. For this field that is remarkably consistent. The heterogeneity, however, has to be judged separately: in the 2020 paper it was in the moderate range, while the 2024 paper reports considerable heterogeneity. On top of that, the diagnostic criteria differ between countries.
The indirect routes are the better documented ones here. That is a little unromantic, because the image of a metal settling onto the estrogen receptor is far catchier.
In practice, though, it is the better news. Thyroid and blood sugar are systems that can be measured and followed. An estrogen receptor in a cell culture is not.
And now you know why, with me, a thyroid panel and a look at blood sugar often stand at the beginning instead of a metal profile. The path runs through the systems I can actually observe.
Where cadmium and lead come from, and how to read measured values
Up to here the question was whether metals could have something to do with your hormones. Now the question that brings more in everyday life: where do they come from, and what does a test show.
The sources, sorted by weight
One source towers above all others: tobacco smoke. The tobacco plant accumulates cadmium from the soil, and the lung takes it up far more efficiently than the gut.
Who: A team around Meltzer, 2016, Journal of Trace Elements in Medicine and Biology, Norwegian Institute of Public Health, Oslo. 267 smoking women of childbearing age from the HUNT2 cohort compared with 448 non-smoking women from the same cohort.
What was observed: Blood cadmium rose in the order never smoked, formerly smoked, moderately smoked, heavily smoked, and did so in all subgroups by age, education, body weight and ferritin. Lead was also higher in smokers, but less clearly. Manganese and cobalt showed no relation to smoking. And with heavy smoking, ferritin was no longer a significant factor, there the intensity and duration of smoking dominated.
What this means for you: As long as smoking continues, everything else is fine tuning. Only afterwards does iron status become the decisive dial. Values in former smokers stay elevated for a long time, because cadmium remains in the kidney cortex for decades.
Meltzer HM, Alexander J, Brantsæter AL et al. J Trace Elem Med Biol. 2016;38:165-173. DOI: 10.1016/j.jtemb.2016.04.008 · PMID: 27108098 [Cohort, n=715]I write this without a wagging finger. Smoking is not a character flaw, it is a dependency, and quitting is hard. But leaving this number out would make the whole rest of the article dishonest. It is the largest single lever in this topic.
Through food the distribution is broader and the amounts are smaller. The Austrian agency for health and food safety compiled measured values for this from the years 2010 to 2017: algae around 1800 micrograms per kilogram, cocoa about 179, seafood 136, mushrooms 128, oilseeds 110, organ meats 41 and grains around 30.
Why the ranking is not the amount eaten
- A high content does not mean a high intake.
- Grains and vegetables sit far down the content ranking and still near the top for intake, because a lot of them is eaten daily. Algae sit at the top and play practically no role for most people.
- The soil has a say.
- Contents in grains and vegetables depend on regional soil load and fertiliser use. The same food can differ considerably depending on origin.
- The official reference point comes from the kidney.
- The tolerable weekly intake of the European food safety authority is 2.5 micrograms per kilogram of body weight per week. It is derived from a kidney marker, not from hormones. That is why agency pages are silent about endometriosis. This is not an omission, the endpoint is simply a different one.
EFSA Panel on Contaminants in the Food Chain. Statement on tolerable weekly intake for cadmium. EFSA Journal. 2011;9(2):1975. DOI: 10.2903/j.efsa.2011.1975 [Guideline]
Measuring: what each test answers and what it does not
This is where serious and unserious handling of the topic part ways. Not in whether measuring happens, but in which question a measured value is trusted to answer.
| Material | What it reflects | What it is good for | Limit |
|---|---|---|---|
| Cadmium in blood | more recent intake, weeks to months | current exposure, smoking status | says little about the store |
| Cadmium in urine | the long-term store of the kidney cortex over ten to thirty years | cumulative exposure | varies with kidney function and dilution, hence the creatinine reference |
| Lead in blood | the freely circulating fraction | current situation, follow-up | the bone store stays invisible |
| Lead in bone | the lifetime burden | research | X-ray fluorescence, not available in routine care |
| Hair mineral analysis | contested, see below | not suitable for this question | laboratory deviations of more than tenfold |
| Provocation test | excretion after a chelating agent | not recommended for diagnostics | no established reference standard |
How closely dietary intake and measured value hang together was examined in a Swedish paper at the Karolinska Institute. 57 non-smoking women collected duplicate portions of their food over four days, while blood and urine were measured in parallel. The partial correlation between dietary cadmium and urine was 0.43. And now the sentence that matters: taking iron status into account, it rose to 0.54. Two women with the same plate can carry different amounts of cadmium in the body.
In Germany there are official assessment values for cadmium in urine. The human biomonitoring commission of the Federal Environment Agency works in two steps: below the first level, no health impairment is to be expected according to current knowledge, above the second level an impairment is possible and environmental medical care is indicated. I deliberately do not name concrete numbers, because the values circulating online come from secondary sources and assessment values are adjusted over the years. They belong in the discussion of your results. Which test makes sense when is covered under measuring heavy metals in blood or urine.
Hair mineral analysis: one split sample sent to six laboratories
In 2001, JAMA published an investigation worth knowing before spending money on a hair analysis. A single scalp-near hair sample from a healthy volunteer was split and sent to six commercial laboratories that together served about 90 percent of the American market.
For twelve minerals, the highest and lowest reported values differed by more than tenfold. For 14 of 31 minerals analysed by three or more laboratories, statistically significant extreme values occurred. The reference ranges differed so strongly that nearly all analytes were classified inconsistently by different laboratories as high, normal or low. The laboratories gave mutually contradictory dietary recommendations.
This is not an article of faith and not an opinion about alternative medicine. It is a laboratory experiment with a split sample. For the question of whether metals play a role in your hormonal complaints, this test provides no reliable basis.
Seidel S, Kreutzer R, Smith D, McNeel S, Gilliss D. JAMA. 2001;285(1):67-72. DOI: 10.1001/jama.285.1.67 · PMID: 11150111 [Validation Study, real-world]With the provocation test the situation is similarly clear. A chelating agent such as DMPS or DMSA raises metal excretion in urine in every person, even without elevated exposure, and established comparison values for this situation do not exist. The American College of Medical Toxicology positioned itself explicitly against the use of this test for diagnostics in 2010, because the predictive value is not documented. We cover both procedures in detail under hair mineral analysis in review and DMPS and the provocation test.
A test is only as good as the question it is meant to answer. Do not measure in order to find something. Measure in order to settle a question you formulated beforehand. If the same uncertainty remains after the result as before it, it was the wrong question.
And now you know why I sometimes forgo a test even though it would be technically available. A result from which no action follows produces mainly one thing: worry.
What may actually lower intake, and where keeping perspective begins
If you have read this far, you know my position. The mechanisms are good, the human data inconsistent, and the only randomised study in the entire field concerns calcium and blood lead. There is no randomised study in humans showing that lowering the metal burden changes hormonal complaints. Everyone reading about this topic should know that sentence.
Even so, the order in which one can act is not arbitrary. It follows the strength of the evidence, and it is remarkably unspectacular.
First: avoiding sources
The largest lever is quitting smoking. Not the second largest, the largest. It is not comparable to any dietary change. If it is not possible right now, it may be possible later, and everything else stays sensible regardless. Quitting deserves support, and there are good services for that.
With food it is not about a ban list but about variety. Anyone who eats grains from different sources, who treats organ meats and shellfish as an occasion rather than a habit, has understood the point. With dried algae products, deliberate restraint can genuinely be worthwhile, because the contents there are orders of magnitude higher.
Second: iron status. The practical core of the whole topic
This is the paragraph I wrote this article for. The gut has a transporter for divalent metals, DMT1. It is actually meant for iron, but it is not choosy, and cadmium, manganese and cobalt fit through it as well.
Now the decisive point. When your iron store falls, your body builds more of these transporters in order to catch more iron. And with the iron, more cadmium can come along. The body is not doing anything wrong. It is prioritising.
Who: A team around Meltzer, 2010, Environmental Research, Norwegian Institute of Public Health. 448 healthy, menstruating, non-smoking women between 20 and 55 years of age from the HUNT2 cohort. 257 were iron depleted, 84 had iron deficiency anaemia.
What was observed: Women with low ferritin had raised blood concentrations of manganese, cobalt and cadmium, with normal values for copper and zinc. In the regression models, ferritin was the most important determinant of these three metals, each with p below 0.001. And the number that sticks: around 26 percent of the women with iron deficiency anaemia had high concentrations of all three metals, compared with 2.3 percent of the women with good iron stores.
What this means for you: Whoever stores little iron takes up more cadmium. Women with heavy periods are systematically more often affected. This is not an exotic connection, this is everyday life.
Meltzer HM, Brantsaeter AL, Borch-Iohnsen B et al. Environ Res. 2010;110(5):497-504. DOI: 10.1016/j.envres.2010.03.006 · PMID: 20381026 [Cohort, n=448]A small Japanese paper on 25 young women found the same pattern: blood and urine cadmium behaved inversely to haemoglobin, serum iron and ferritin. Too small to build anything on, but it fits the picture.
A good iron store is the only lever in this topic that stays sensible even if the metal question turns out to play no role. It can influence energy, sleep, hair, thyroid and cycle. And, incidentally, the uptake of cadmium. That is exactly why it stands far forward with me, long before anyone talks about elimination.
How to interpret your iron status is covered under iron deficiency and the right blood values. Why heavy periods are the most common reason for low stores, under iron deficiency through menstruation. A second ferritin guide helps nobody, so I will not repeat that here.
Third: zinc and calcium, honestly placed
Zinc is the partner of metallothionein, that sulphur-rich protein which binds cadmium. From this it is often concluded that plenty of zinc protects against cadmium. The evidence for that comes from the rat model and is thinner than assumed.
Who: A team around Rogalska, 2011, Chemico-Biological Interactions, Medical University of Bialystok, Poland. Wistar rats received zinc at two doses and cadmium at two doses over six months.
What was observed: Cadmium led dose-dependently to apoptosis, inflammation and necrosis in the liver. Zinc prevented part of the changes, but not the necrosis. The higher zinc dose even intensified the necrosis at high cadmium exposure. The lower zinc dose was more favourable than the higher one at both cadmium levels.
What this means for you: Zinc is not an antidote following the principle that more is better. This finding is missing from almost every guide text. And because these are rats, no dose for humans can be derived from it, in either direction.
Rogalska J, Pilat-Marcinkiewicz B, Brzóska MM. Chem Biol Interact. 2011;193(3):191-203. DOI: 10.1016/j.cbi.2011.05.008 · PMID: 21627960 [In vivo, rat]With calcium the situation is better, because there the randomised evidence exists. There too the effect was moderate and limited to a subgroup. In pregnancy and while breastfeeding, every supplement belongs under medical supervision.
What deliberately does not appear here
The limits of this article
- No elimination protocol. For the question of whether lowering the metal burden changes hormonal complaints, there is no human study with a hormonal endpoint.
- No chelation therapy. It is a medical treatment with its own risks, above all for the kidneys and the electrolyte balance. It is named here and explicitly not recommended.
- No doses and no products. Every concrete number in this text comes from a study. That is literature, not a prescription.
- No statement on chlorella, coriander or zeolite in the hormonal context. A separate assessment is under natural heavy metal elimination.
- No recommendation on glutathione in this context. The body's own detoxification is a topic of its own, to be read under glutathione and heavy metals.
And now the paragraph that matters most to me
Environmental medicine has a side effect that is talked about too rarely. It can create fear. And fear looks for control.
I see this regularly. Someone reads about cadmium in grains and cuts out whole grains. Then about lead in spices, cuts out spices. Then about mercury, cuts out even more. In the end the plate is small, the worry large and the nutrient supply worse than before.
Whole grains, legumes and vegetables are among the best documented building blocks of good nutrition. Their cadmium content does not change that. The largest prospective work on dietary cadmium and hormone-dependent cancers, with 23815 women over up to 17 years, simply found no association.
If thinking about food starts to narrow what you eat, to dominate your evenings or to make eating with others an effort, then it is no longer prevention. Then it is a topic of its own that deserves attention. We have a separate text on it: eating disorders between body and mind.
And now you know why, in the consulting room, I ask about smoking, ferritin and bleeding intensity before I talk about metals. Not because metals were irrelevant. But because the questions before decide more about your everyday life than any laboratory value after.
What I see clinically, clearly named as observation
Documented by human studies: Smoking is the largest cadmium source. Low ferritin goes along with higher cadmium values. Calcium can lower blood lead in a subgroup of breastfeeding women. Mercury shifts thyroid values in meta-analyses.
Mechanistically plausible, human data thin: Cadmium at the estrogen receptor, the GPER route in fibroid cells, the idea that complaints arise from this in humans.
Clinical tradition without a strong study base: Elimination concepts for hormonal complaints. I do not use them here, because there is no endpoint against which success could be measured.
What I observe clinically: that women with heavy periods, low ferritin and a long smoking history come strikingly often with a bundle of unclear complaints. Whether cadmium plays a role of its own in this or is merely riding along, I cannot separate out. I say that openly instead of claiming otherwise.
Common questions from the consulting room
What is a metalloestrogen, in plain language?
The term comes from a 2006 review and describes metal ions that can bind to the estrogen receptor and trigger an estrogen-like response there. Among those named are aluminium, antimony, arsenite, barium, cadmium, chromium, cobalt, copper, lead, mercury, nickel, selenite, tin and vanadate. The framing matters: the word describes a mechanism in the laboratory, not a diagnosis and not a cause of disease.
Can cadmium act like estrogen, or is that only cell culture?
Both are true. Binding to estrogen receptor alpha was measured cleanly in cell culture in 2000, with a dissociation constant of roughly 4 to 5 times 10 to the minus 10 moles per litre. In 2003, a rat model showed a heavier uterus and a more branched mammary gland after cadmium exposure. In humans, none of this is documented yet. These are cell and animal data, and they justify a question, not a diagnosis.
Is cadmium the cause of my endometriosis?
There is no basis for that. A US cross-sectional analysis found a prevalence ratio of 2.0 in the middle cadmium quartiles, but only 1.6 in the highest quartile, so no clean dose gradient. The study with the best diagnostic certainty, in which endometriosis was surgically confirmed, actually found a lower probability for cadmium in blood. Endometriosis is a medical diagnosis with many contributing factors, and nobody brings it on themselves through environmental exposure.
Do heavy metals raise the risk of fibroids?
The picture is somewhat more consistent than for endometriosis, but still weak. In a surgical cohort the adjusted odds were 1.44 for cadmium and 1.31 for lead in whole blood, while urine values were not associated. The prospective ultrasound study with 1132 women explicitly calls its own findings weak and imprecise, with a clearer signal only in vitamin D deficiency. The authors themselves consider that a fibroid might also bind the metals rather than be caused by them.
Do heavy metals bring menopause forward?
That is the common claim for cadmium, yet the most recent work shows the opposite. In 414 early postmenopausal women, menopause occurred on average 1.30 years later per unit of log-transformed cadmium. For lead the same work found 1.25 years earlier. Both are cross-sectional data, the authors themselves warn about reverse temporality, and the metal mixture as a whole showed no association.
Do heavy metals affect fertility, and does that only concern the woman?
The most robust work on this followed 501 couples from the moment they stopped contraception. A longer time to pregnancy appeared for cadmium in the woman with a fecundability odds ratio of 0.78, and for lead in the man with 0.85. In the joint couple model only lead in the man remained. So fertility is a couple matter. If you are trying to conceive, reproductive medical assessment belongs at the beginning and not at the end, because time is a real factor here.
Where does cadmium come from in everyday life, and what is the biggest source?
Tobacco smoke is by far the largest single source. In the Norwegian HUNT2 cohort, blood cadmium values rose in the order never smoked, formerly smoked, moderately smoked, heavily smoked, and did so in every subgroup by age, education, body weight and ferritin. In food, grains and vegetables contribute most, depending on soil load, along with organ meats, shellfish, cocoa, oilseeds, mushrooms and dried algae. The EFSA tolerable weekly intake is 2.5 micrograms per kilogram of body weight per week.
I stopped smoking, is the cadmium gone now?
Not immediately. Cadmium accumulates in the kidney cortex over decades, which is why values in former smokers stay above those of people who never smoked for a long time. That is exactly what the HUNT2 cohort showed. This is not an argument against quitting, quite the opposite: quitting stops the resupply, and everything else simply needs time after that.
Which test shows a heavy metal burden: blood, urine or hair?
Blood and urine answer different questions. Cadmium in blood reflects more recent intake, cadmium in urine reflects more the long-term kidney store built over decades. For lead, blood shows the freely circulating fraction, while the bone store only becomes visible with special X-ray methods that are not available in routine care. Which value makes sense depends on the question you want answered.
What should I make of hair mineral analysis for hormonal complaints?
For this question it provides no reliable basis. An investigation published in JAMA split a single hair sample and sent it to six commercial laboratories. For twelve minerals the highest and lowest reported values differed by more than tenfold, and nearly all analytes were classified inconsistently by the laboratories as high, normal or low. The authors advise against using such analyses to assess nutrient status or suspected environmental exposure.
Does a provocation test with DMPS or DMSA bring clarity?
For diagnosing a burden it is not suitable. A chelating agent raises metal excretion in urine in every person, including people without elevated exposure. That is precisely why the American College of Medical Toxicology positions itself against the use of this test for diagnostics in a 2010 position statement. A high value after provocation proves nothing, because there is no established reference standard for it.
Why does my ferritin matter when it comes to cadmium?
Because iron and cadmium share the same transporter in the intestinal wall. When the iron store falls, the body builds more transporters, and then more cadmium comes along too. In a Norwegian study of 448 non-smoking women, ferritin was the most important determinant of cadmium, manganese and cobalt in blood. Around 26 percent of women with iron deficiency anaemia had high values of all three metals, compared with 2.3 percent of women with good iron stores. Women with heavy periods are systematically more often affected.
Is lead released from the bones during menopause?
The evidence is open. In a survey of 903 women in Mexico City, blood lead values after menopause were on average 0.76 micrograms per decilitre higher, with a maximum between ages 47 and 50. A prospective study of 91 women after bilateral removal of the ovaries, by contrast, found only a rise of 0.4 micrograms per decilitre after six months and no decrease of lead in the shin bone. Both findings stand side by side, and this question is not settled.
What does mercury have to do with my sex hormones?
The path runs indirectly through the thyroid. A meta-analysis of 13 papers found mercury in blood associated with a higher TSH and a higher FT4. In a Spanish pregnancy cohort of 1407 women, an inverse association with total T3 appeared, more clearly in women who supplemented iodine. The thyroid co-regulates cycle length, ovulation and bleeding intensity, which is why it is the connecting link. These effects are shifts in laboratory values, not diagnoses.
Should I have my metal values measured before trying to conceive?
That is a question for a medical conversation and not one an article can answer. The order matters: reproductive medical assessment is the first step and is not replaced or postponed by any environmental question, because time is a real factor when trying to conceive. What remains sensible regardless is quitting smoking in both partners and an orderly iron, zinc and calcium status. In pregnancy and while breastfeeding, every supplement belongs under medical supervision.
Do I now have to cut out whole grains, cocoa and mushrooms?
No. Whole grains, legumes and vegetables are among the best documented building blocks of good nutrition, and their cadmium content does not change that. The largest prospective work on this, with 23815 women over up to 17 years, found no association between estimated dietary cadmium intake and breast, endometrial or ovarian cancer. Variety makes more sense than a list of bans. If thinking about food starts to narrow what you eat, that is a topic in its own right and a good reason to talk about it.
Where this topic connects to the rest of your system
Metals are one puzzle piece. They hang on your iron status, on your thyroid, on your blood sugar and on how you handle uncertainty. Here are the texts that carry on at each of those points.
Hormonal imbalance in women
The large overview article of the cluster. It lays out the whole system, into which this text draws only one causal trace.
If your bleeding is heavyIron deficiency through menstruation
The most important practical follow-on from this article. Low ferritin may raise cadmium uptake through the shared transporter.
If you want to interpret your storeIron deficiency and the right blood values
Which values are needed for iron status and why haemoglobin alone reacts too late.
If you are thinking about testingMeasuring heavy metals in blood or urine
Which material answers which question, with the details on sampling and assessment values.
If the other substance group interests youXenoestrogens in everyday life
The organic endocrine disruptors from plastic, cosmetics and packaging. A different substance class, similar questions at the receptor.
If mould is the subjectZearalenone and hormones
The best documented mycoestrogen. The third family alongside xenoestrogens and metalloestrogens.
If you have endometriosisEndometriosis seen integratively
The condition in a larger context, with the immune system, inflammation and pain processing.
If your cycle is restlessThyroid and female hormones
The pacemaker behind cycle length, bleeding intensity and ovulation. Also the connecting link to mercury.
If you want to start at the breakdownEstrogen breakdown through the liver
How estrogens are disposed of and why liver and gut belong together in hormone topics.
If exhaustion is in the foregroundHeavy metals, fatigue and exhaustion
What is actually known about this most common reason for a metal test, and what is not.
If PCOS is on the tableUnderstanding PCO syndrome
The diagnosis in which insulin and androgens work together. A path of its own that gets by without metals.
If eating gets narrowEating disorders between body and mind
For the moment when prevention turns into control. An important text alongside this article.
If you want the whole pictureWhy I look for environmental factors
Why I look for environmental factors in hormonal symptoms, along which grid, and when that search adds nothing.
If you want the detail on the substanceBisphenol A and your hormones
The substance from tins and till receipts, the 2023 EFSA reassessment and what BPA free does and does not mean.
If you want to place drinking water and cookwarePFAS: the forever chemicals
Why the forever chemicals stay in the body for years and where individual avoidance reaches its limit.
If the endometriosis trail interests youDioxins, PCBs and endometriosis
The 1993 monkey study, the Seveso cohort and what does and does not follow from them today.
Scientific sources
- Darbre PD. Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast. J Appl Toxicol. 2006;26(3):191-197. PMID: 16489580 · DOI: 10.1002/jat.1135 [Mechanism Review]
- Stoica A, Katzenellenbogen BS, Martin MB. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol. 2000;14(4):545-553. PMID: 10770491 · DOI: 10.1210/mend.14.4.0441 [In vitro]
- Johnson MD, Kenney N, Stoica A et al. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med. 2003;9(8):1081-1084. PMID: 12858169 · DOI: 10.1038/nm902 [In vivo, rat]
- Divekar SD, Li HH, Parodi DA et al. Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020;41(7):1005-1014. PMID: 31646340 · DOI: 10.1093/carcin/bgz176 [In vivo, rat]
- Yu L, Liu J, Yan Y et al. Metalloestrogenic effects of cadmium downstream of G protein-coupled estrogen receptor and mitogen-activated protein kinase pathways in human uterine fibroid cells. Arch Toxicol. 2021;95(6):1995-2006. PMID: 33818655 · DOI: 10.1007/s00204-021-03033-z [In vitro]
- Rogalska J, Pilat-Marcinkiewicz B, Brzóska MM. Protective effect of zinc against cadmium hepatotoxicity depends on this bioelement intake and level of cadmium exposure: a study in a rat model. Chem Biol Interact. 2011;193(3):191-203. PMID: 21627960 · DOI: 10.1016/j.cbi.2011.05.008 [In vivo, rat]
- Pollack AZ, Schisterman EF, Goldman LR et al. Cadmium, lead, and mercury in relation to reproductive hormones and anovulation in premenopausal women. Environ Health Perspect. 2011;119(8):1156-1161. PMID: 21543284 · DOI: 10.1289/ehp.1003284 [Cohort, n=252]
- Ding N, Wang X, Harlow SD, Randolph JF, Gold EB, Park SK. Heavy Metals and Trajectories of Anti-Müllerian Hormone During the Menopausal Transition. J Clin Endocrinol Metab. 2024;109(11):e2057-e2064. PMID: 38271266 · DOI: 10.1210/clinem/dgad756 [Cohort, longitudinal, n=549]
- Génard-Walton M, Warembourg C, Duros S et al. Heavy metals and diminished ovarian reserve: single-exposure and mixture analyses amongst women consulting in French fertility centres. Reprod Biomed Online. 2023;47(3):103241. PMID: 37451971 · DOI: 10.1016/j.rbmo.2023.05.013 [Case-Control, n=292]
- Hall MS, Talge NM, Upson K. Urinary cadmium and endometriosis prevalence in a US nationally representative sample: results from NHANES 1999-2006. Hum Reprod. 2023;38(9):1835-1842. PMID: 37487110 · DOI: 10.1093/humrep/dead117 [Cross-sectional]
- Pollack AZ, Buck Louis GM, Chen Z et al. Trace elements and endometriosis: the ENDO study. Reprod Toxicol. 2013;42:41-48. PMID: 23892002 · DOI: 10.1016/j.reprotox.2013.05.009 [Cohort]
- Johnstone EB, Buck Louis GM, Parsons PJ et al. Increased urinary cobalt and whole blood concentrations of cadmium and lead in women with uterine leiomyomata: Findings from the ENDO Study. Reprod Toxicol. 2014;49:27-32. PMID: 24994689 · DOI: 10.1016/j.reprotox.2014.06.007 [Cohort]
- Geller RJ, Wesselink AK, Claus Henn B et al. A Prospective Ultrasound Study of Whole Blood Metals and Incidence of Uterine Leiomyomata. Environ Health Perspect. 2025;133(3-4):47012. PMID: 40063901 · DOI: 10.1289/EHP15218 [Cohort, prospective]
- Yin G, Zhao S, Wu J, Xu Q. Body mass index and sleep duration may regulate the effect of heavy metals on age at menopause. BMC Public Health. 2025;26(1):26. PMID: 41316068 · DOI: 10.1186/s12889-025-25306-3 [Cross-sectional]
- Buck Louis GM, Sundaram R, Schisterman EF et al. Heavy metals and couple fecundity, the LIFE Study. Chemosphere. 2012;87(11):1201-1207. PMID: 22309709 · DOI: 10.1016/j.chemosphere.2012.01.017 [Cohort, prospective, 501 couples]
- Buck Louis GM, Barr DB, Kannan K, Chen Z, Kim S, Sundaram R. Paternal exposures to environmental chemicals and time-to-pregnancy: overview of results from the LIFE study. Andrology. 2016;4(4):639-647. PMID: 27061873 · DOI: 10.1111/andr.12171 [Review]
- Zhong Z, Yang Q, Li C, Chen X, Zhou F. A global perspective of correlation between maternal blood lead levels and risks of preeclampsia: An updated systematic review and meta-analysis. Front Public Health. 2022;10:1072052. PMID: 36620238 · DOI: 10.3389/fpubh.2022.1072052 [Meta-analysis, k=21]
- Hernandez-Avila M, Villalpando CG, Palazuelos E, Hu H, Villalpando ME, Martinez DR. Determinants of blood lead levels across the menopausal transition. Arch Environ Health. 2000;55(5):355-360. PMID: 11063411 · DOI: 10.1080/00039890009604028 [Cross-sectional, n=903]
- Berkowitz GS, Wolff MS, Lapinski RH, Todd AC. Prospective study of blood and tibia lead in women undergoing surgical menopause. Environ Health Perspect. 2004;112(17):1673-1678. PMID: 15579412 · DOI: 10.1289/ehp.7005 [Cohort, prospective, n=91]
- Hernandez-Avila M, Gonzalez-Cossio T, Hernandez-Avila JE et al. Dietary calcium supplements to lower blood lead levels in lactating women: a randomized placebo-controlled trial. Epidemiology. 2003;14(2):206-212. PMID: 12606887 · DOI: 10.1097/01.EDE.0000038520.66094.34 [RCT, n=617]
- Hu Q, Han X, Dong G et al. Association between mercury exposure and thyroid hormones levels: A meta-analysis. Environ Res. 2021;196:110928. PMID: 33640496 · DOI: 10.1016/j.envres.2021.110928 [Meta-analysis, k=13]
- Llop S, Lopez-Espinosa MJ, Murcia M et al. Synergism between exposure to mercury and use of iodine supplements on thyroid hormones in pregnant women. Environ Res. 2015;138:298-305. PMID: 25749125 · DOI: 10.1016/j.envres.2015.02.026 [Cohort, n=1407]
- Salmeri N, Villanacci R, Ottolina J et al. Maternal Arsenic Exposure and Gestational Diabetes: A Systematic Review and Meta-Analysis. Nutrients. 2020;12(10):3094. PMID: 33050632 · DOI: 10.3390/nu12103094 [Meta-analysis, Systematic Review]
- Wu R, Duan M, Zong D, Li Z. Effect of arsenic on the risk of gestational diabetes mellitus: a systematic review and meta-analysis. BMC Public Health. 2024;24(1):1131. PMID: 38654206 · DOI: 10.1186/s12889-024-18596-6 [Meta-analysis, k=13]
- Meltzer HM, Brantsaeter AL, Borch-Iohnsen B et al. Low iron stores are related to higher blood concentrations of manganese, cobalt and cadmium in non-smoking, Norwegian women in the HUNT 2 study. Environ Res. 2010;110(5):497-504. PMID: 20381026 · DOI: 10.1016/j.envres.2010.03.006 [Cohort, n=448]
- Meltzer HM, Alexander J, Brantsæter AL et al. The impact of iron status and smoking on blood divalent metal concentrations in Norwegian women in the HUNT2 Study. J Trace Elem Med Biol. 2016;38:165-173. PMID: 27108098 · DOI: 10.1016/j.jtemb.2016.04.008 [Cohort, n=267]
- Julin B, Vahter M, Amzal B, Wolk A, Berglund M, Åkesson A. Relation between dietary cadmium intake and biomarkers of cadmium exposure in premenopausal women accounting for body iron stores. Environ Health. 2011;10:105. PMID: 22177271 · DOI: 10.1186/1476-069X-10-105 [Cohort, n=57]
- Murashima M, Kikuchi Y, Nomiyama T, Kumagai N, Omae K, Watanabe S. Intake and excretion of cadmium and iron balance and influence of dietary habits among young women. Nihon Eiseigaku Zasshi. 2004;59(1):31-37. PMID: 15007902 · DOI: 10.1265/jjh.59.31 [Cohort, n=25, small]
- Eriksen KT, Halkjær J, Sørensen M et al. Dietary cadmium intake and risk of breast, endometrial and ovarian cancer in Danish postmenopausal women: a prospective cohort study. PLoS One. 2014;9(6):e100815. PMID: 24963789 · DOI: 10.1371/journal.pone.0100815 [Cohort, prospective, n=23815]
- Seidel S, Kreutzer R, Smith D, McNeel S, Gilliss D. Assessment of commercial laboratories performing hair mineral analysis. JAMA. 2001;285(1):67-72. PMID: 11150111 · DOI: 10.1001/jama.285.1.67 [Validation Study, real-world]
- American College of Medical Toxicology. American College of Medical Toxicology position statement on post-chelator challenge urinary metal testing. J Med Toxicol. 2010;6(1):74-75. PMID: 20354920 · DOI: 10.1007/s13181-010-0039-0 [Guideline, Consensus Statement]
- German Human Biomonitoring Commission of the Federal Environment Agency. Aktualisierung der Stoffmonographie Cadmium: Referenz- und Human-Biomonitoring-Werte. Bundesgesundheitsblatt. 2011;54:981-996. DOI: 10.1007/s00103-011-1327-9 [Guideline, agency document]
- Gore AC, Chappell VA, Fenton SE et al. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015;36(6):E1-E150. PMID: 26544531 · DOI: 10.1210/er.2015-1010 [Guideline, Consensus Statement]
- EFSA Panel on Contaminants in the Food Chain. Cadmium in food: Scientific opinion of the Panel on Contaminants in the Food Chain. EFSA Journal. 2009;7(3):980. DOI: 10.2903/j.efsa.2009.980 [Guideline, agency document]
- EFSA Panel on Contaminants in the Food Chain. Statement on tolerable weekly intake for cadmium. EFSA Journal. 2011;9(2):1975. DOI: 10.2903/j.efsa.2011.1975 [Guideline, agency document]
- EFSA. Cadmium dietary exposure in the European population. EFSA Journal. 2012;10(1):2551. DOI: 10.2903/j.efsa.2012.2551 [Guideline, agency document]
- Austrian Agency for Health and Food Safety (AGES). Cadmium in Lebensmitteln: Gehalte aus der amtlichen Kontrolle 2010 bis 2017. Substance information, Vienna. ages.at [Agency document]
- There is no intervention study with a hormonal endpoint. For the question of whether lowering the metal burden changes hormonal complaints, no randomised study in humans exists. The only randomised evidence in this collection concerns calcium and blood lead as an intermediate measure, not a symptom picture. That is the most honest reason why guidelines on endometriosis, PCOS and menopause say nothing action-guiding about metals. Not ignorance, but missing intervention data.
- The mechanism comes from cell culture and rats. The binding of cadmium to the estrogen receptor was measured in COS-1 cells, the effects on uterus and mammary gland were observed in Sprague-Dawley rats. Dose, route of administration and species differ fundamentally from the everyday exposure of a human being.
- On endometriosis, two good studies contradict each other. The NHANES analysis found raised prevalence ratios without a clean dose gradient and with a self-reported diagnosis. The ENDO study with a surgically confirmed diagnosis found the opposite for blood cadmium. This contradiction is not dissolved here, because the data do not dissolve it.
- For fibroids the prospective effect is weak. The authors of the SELF cohort describe their own findings as weak and imprecise. Individual point estimates are missing from the published abstract, which is why only confidence intervals and the study group's own assessment appear here.
- Reverse causality is possible everywhere. A fibroid could bind metals rather than being caused by them. Bone remodelling after menopause could release lead rather than lead bringing menopause forward. Both explanations produce the same numbers as the opposite reading.
- Smoking is the large confounder. It is at once the largest cadmium source and an independent factor for fertility and the timing of menopause. Studies that do not adjust for it cleanly easily measure one thing and name the other.
- On the zinc question there are only animal data, and they are not linear. In the rat model the higher zinc dose was less favourable than the lower one at high cadmium exposure. No amount for humans can be derived from that, in either direction.
- The assessment values for cadmium in urine deliberately appear here without a number. The values circulating online come from secondary sources, and assessment values are adjusted over the years. The EFSA reference value is moreover derived from a kidney marker and not from hormonal endpoints.
- The number from the internet that is missing here. The widespread claim that cadmium raises the endometriosis risk 3.4-fold could not be traced to any primary source in PubMed. It is therefore not quoted. The prevalence ratios that can be found are 2.0 and 1.6 with wide intervals.
- The food contents come from an Austrian agency overview and describe measured values from official monitoring. They are contents per kilogram, not statements about actual intake, and they vary greatly by region.
- The Endocrine Society takes a differentiated view. Its second scientific statement on endocrine disrupting chemicals considers the mechanistic basis solid and explicitly names non-monotonic dose-response relationships and particular vulnerability during developmental phases. The same document at the same time urges caution with causal conclusions for humans, because differences in study design make broad generalisations difficult. Both stand in the same source, and both belong in a citation.
- What deliberately does not appear here. No elimination protocol, no dose recommendation, no product, no source for tests. No advice to change, reduce or stop an existing medication, neither the pill nor hormone replacement therapy, thyroid hormones, metformin, antiandrogens or GnRH analogues. And at no point does it follow from this text that a gynaecological work-up, a laparoscopy or an indicated operation should be postponed. What I describe from my consulting room is marked as observation and is not a study result.